UBS Reduces the Firm's PT on Kimberly-Clark (KMB) Stock

Kimberly-Clark Corporation (NASDAQ:KMB) is one of the Best Depressed Stocks to Buy Right Now. On January 14, UBS reduced the firm’s price objective on Kimberly-Clark Corporation (NASDAQ:KMB)’s stock to $107 from $132, while keeping a “Neutral” rating, as reported by The Fly. The analyst stated that the operating environment and market backdrop for consumer staples are challenging. That being said, the fundamentals can witness improvement in 2026.

Elsewhere, on January 8, TD Cowen reduced the firm’s price objective on the company’s stock to $105 from $112, while keeping a “Hold” rating, as reported by The Fly. Notably, the firm adjusted its price targets in the broader consumer staples group as part of its 2026 outlook. It sees a tough year for large-cap consumer staples, with volume growth unlikely to improve significantly.

In a separate release, Wells Fargo reduced the firm’s price objective on Kimberly-Clark Corporation (NASDAQ:KMB)’s stock to $105 from $110, while keeping an “Equal Weight” rating, as reported by The Fly. As the firm aggregates models throughout beverage/food/HPC, it has been revising its price objectives for 2026.

Kimberly-Clark Corporation (NASDAQ:KMB) manufactures and markets personal care products.

While we acknowledge the potential of KMB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now

Disclosure: None. This article is originally published at Insider Monkey.